This contract opportunity involves the establishment of discount contracts for various pharmaceutical substances under the Open-House procedure, as per § 130a Abs. 8 SGB V. All eligible and interested pharmaceutical companies or consortia are invited to enter into discount contracts for the followin
11 days left to bid. Opened 9 months ago, deadline 1 Sept 2026.
This contract opportunity involves the establishment of discount contracts for various active ingredients under the Open-House procedure, as per § 130a Abs. 8 SGB V. All eligible and interested pharmaceutical companies or consortia are invited to enter into discount contracts under uniform terms and
This announcement is for the establishment of contracts to supply medical dressings to the insured members of AOK NW, in accordance with § 31 SGB V, through an Open-House procedure. All qualified and interested service providers are invited to enter into this contract under uniform contractual condi
Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.
Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.
UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.
Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.
